4.7 Article

The effect of oxidative stress on the mutation rate of Mycobacterium tuberculosis with impaired catalase/peroxidase function

Journal

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 62, Issue 4, Pages 709-712

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/jac/dkn259

Keywords

oxidative stress response; isoniazid; M. tuberculosis

Funding

  1. British Society for Antimicrobial Chemotherapy

Ask authors/readers for more resources

Objectives: To determine the effect of oxidative stress on isoniazid-resistant Mycobacterium tuberculosis deficient in catalase/peroxidase activity to varying degrees through mutation in katG. Methods: The mutation rate was determined for a set of isogenic strains with different katG alleles giving different catalase and/or peroxidase activities following exposure to the oxidizing agent, hydrogen peroxide. Mutants were selected on rifampicin, and the location and nature of the mutation were identified by sequencing the rpoB gene. Results: No evidence was found to suggest that strains that had impaired catalase/peroxidase activity were hypermutable, and the presence of excess hydrogen peroxide had no effect on the mutation rate. An unusual pattern of mutations in rpoB was observed in catalase-deficient strains with only 3 of 66 having mutations within the rifampicin resistance-determining region. Conclusions: The mutation rate of M. tuberculosis in response to oxidative stress is not increased in strains with significant deficits in catalase and peroxidase activity. Our data suggest that isoniazid-resistant strains compensate for their reduced ability to detoxify oxidative stress effectively. Interestingly, mutations were found in unusual locations at positions similar to those found in clinical isoniazid-resistant strains.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

Clinical relevance assessment of animal preclinical research (RAA) tool: development and explanation

Kurinchi S. Gurusamy, David Moher, Marilena Loizidou, Irfan Ahmed, Marc T. Avey, Carly C. Barron, Brian Davidson, Miriam Dwek, Christian Gluud, Gavin Jell, Kiran Katakam, Joshua Montroy, Timothy D. McHugh, Nicola J. Osborne, Merel Ritskes-Hoitinga, Kees van Laarhoven, Jan Vollert, Manoj Lalu

Summary: The study developed a tool to assess the clinical relevance of preclinical studies and refined and developed it using a modified Delphi consensus. The tool consists of eight domains and 28 signaling questions, providing a framework for researchers, journal editors, grant funders, and regulatory authorities to assess the potential clinical relevance of preclinical animal research.

PEERJ (2021)

Article Veterinary Sciences

Results of urinary bacterial cultures and antibiotic susceptibility testing of dogs and cats in the UK

J. D. Fonseca, D. E. Mavrides, P. A. Graham, T. D. McHugh

Summary: Bacterial urinary tract infections are common in small animals, with Escherichia coli being the most prevalent species. Resistance to commonly used antibiotics such as ampicillin and amoxicillin-clavulanic acid is emerging, highlighting the need for continued monitoring of antibiotic resistance in uropathogens. Despite this, fluoroquinolones continue to show good in vitro activity against uropathogens.

JOURNAL OF SMALL ANIMAL PRACTICE (2021)

Article Veterinary Sciences

Antimicrobial resistance profiles of bacteria associated with lower respiratory tract infections in cats and dogs in England

Daphne E. Mavrides, Alice L. Morgan, Jea G. Na, Peter A. Graham, Timothy D. McHugh

Summary: Bacterial lower respiratory tract infections (bLRTIs) are common and potentially life threatening in cats and dogs. Antibiotic treatment is often initiated before the diagnosis of bLRTI; therefore improved knowledge of the aetiology and antibiotic susceptibility patterns of these infections is essential to inform empiric antibiotic choices. The study found resistance to certain first-choice antibiotics in bLRTIs, highlighting the need for continued monitoring and sound evidence to inform decision-making in the management of these infections.

VETERINARY RECORD (2022)

Review Public, Environmental & Occupational Health

Reducing the risk of tuberculosis transmission for HCWs in high incidence settings

Ana Paleckyte, Oshani Dissanayake, Stella Mpagama, Marc C. Lipman, Timothy D. McHugh

Summary: Globally, tuberculosis is a major cause of death and healthcare workers are at increased risk of hospital-acquired TB infection. The World Health Organization has developed an international system of infection prevention and control interventions, but implementation in resource-constrained settings and high TB burden areas is often inadequate. Healthcare workers often underestimate the risk of TB transmission and lack of expertise and funding can lead to unsafe practices and increase the risk of TB dissemination.

ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2021)

Article Microbiology

Epidemiological profile of multidrug-resistant and extensively drug-resistant Mycobacterium Tubrculosis among Congolese patients

Darrel Ornelle Elion Assiana, Jabar Babatunde Pacome Achimi Abdul, Laure Stella Ghoma Linguissi, Micheska Epola, Jeannhey Christevy Vouvoungui, Albert Mabiala, Christopher Mebiame Biyogho, Jean Ronald Edoa, Bayode Romeo Adegbite, Ayola Akim Adegnika, Linzy Elton, Julio Ortiz Canseco, Timothy D. McHugh, Gabriel Ahombo, Francine Ntoumi

Summary: This study in the Republic of Congo implemented molecular tools to diagnose MDR and XDR-TB among presumptive tuberculosis patients. Results showed a high rate of rifampicin resistance and the presence of extensively drug-resistant tuberculosis in new patients, highlighting the need for further studies on TB drug resistance in the country.

ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2021)

Review Microbiology

Application of Bacteriophages for Mycobacterial Infections, from Diagnosis to Treatment

Christopher G. Shield, Benjamin M. C. Swift, Timothy D. McHugh, Rebekah M. Dedrick, Graham F. Hatfull, Giovanni Satta

Summary: Mycobacterium tuberculosis and other non-tuberculous mycobacteria cause various infections, with difficulties in diagnosis and treatment. Bacteriophages have emerged as potential new technologies for diagnosis and treatment in recent years.

MICROORGANISMS (2021)

Article Microbiology

Culture-Free Enumeration of Mycobacterium tuberculosis in Mouse Tissues Using the Molecular Bacterial Load Assay for Preclinical Drug Development

Dimitrios Evangelopoulos, Carolyn M. Shoen, Isobella Honeyborne, Simon Clark, Ann Williams, Galina V. Mukamolova, Michael H. Cynamon, Timothy D. McHugh

Summary: We report the adaptation of a culture-free assay for counting the bacterial load in animal tissues, which can accurately detect bacteria that cannot grow on solid culture media. This assay has the potential to decrease the readout time of data acquisition from animal experiments and could be a valuable tool for tuberculosis drug discovery and development.

MICROORGANISMS (2022)

Article Infectious Diseases

Improving the Drug Development Pipeline for Mycobacteria: Modelling Antibiotic Exposure in the Hollow Fibre Infection Model

Arundhati Maitra, Priya Solanki, Zahra Sadouki, Timothy D. McHugh, Frank Kloprogge

Summary: Mycobacterial infections are challenging to treat, with limited options due to antibiotic resistance. Drug development is resource-intensive and high-risk, leading to market failure in antimicrobial drug discovery programs. The hollow fibre infection model (HFIM) is an effective tool for evaluating the efficacy of drug combinations.

ANTIBIOTICS-BASEL (2021)

Article Infectious Diseases

Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid

Anna Bateson, Julio Ortiz Canseco, Timothy D. McHugh, Adam A. Witney, Silke Feuerriegel, Matthias Merker, Thomas A. Kohl, Christian Utpatel, Stefan Niemann, Sonke Andres, Katharina Kranzer, Florian P. Maurer, Arash Ghodousi, Emanuele Borroni, Daniela Maria Cirillo, Maria Wijkander, Juan C. Toro, Ramona Groenheit, Jim Werngren, Diana Machado, Miguel Viveiros, Robin M. Warren, Frederick Sirgel, Anzaan Dippenaar, Claudio U. Koeser, Eugene Sun, Juliano Timm

Summary: The study reveals ancient differences in susceptibility to pretomanid among different lineages of Mycobacterium tuberculosis complex (MTBC) and recent emergence of resistance. The findings highlight the significance of considering global diversity of MTBC in clinical drug development and defining breakpoints for antimicrobial susceptibility testing.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

Article Medicine, General & Internal

Verona integron-encoded metallo-Beta-lactamase (VIM) and Vietnam extended-spectrum Beta-lactamase (VEB) producing pseudomonas balearica from a clinical specimen

Fakhur Uddin, Muhammad Sohail, Qurban Hussain Shaikh, Mir Tahir Hussain, Kerry Roulston, Timothy Daniel McHugh

Summary: Pseudomonas balearica, a saprophyte found in marshy and marine habitats, was identified using MALDI-TOF-MS and 16S rDNA sequence from a patient admitted to an intensive care unit. The isolate was found to be resistant to multiple antibiotics and can be a potential source for the horizontal transfer of certain genes. Its pathogenesis remains to be understood.

JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION (2022)

Article Microbiology

Pre-Clinical Tools for Predicting Drug Efficacy in Treatment of Tuberculosis

Hasmik Margaryan, Dimitrios D. Evangelopoulos, Leticia Muraro Wildner, Timothy D. McHugh

Summary: Combination therapy has shown some success in limiting drug-resistant tuberculosis by simultaneously acting on different targets and pathways. It also helps in shortening the duration of therapy. Systems biology approaches are used to analyze the cellular processes of mycobacteria and identify the networks and pathways associated with M. tuberculosis infection and survival. However, the most predictive combination of preclinical models for assessing clinical treatment efficacy remains unclear.

MICROORGANISMS (2022)

Correction Microbiology

Detection of carbapenemases blaOXA48-blaKPC-blaNDM-blaVIM and extended-spectrum-β-lactamase blaOXA1-blaSHV-blaTEM genes in Gram-negative bacterial isolates from ICU burns patients (vol 21, 1, 2021)

Muhammad Hayat Haider, Timothy D. McHugh, Kerry Roulston, Lia Barbara Arruda, Zahra Sadouki, Saba Riaz

ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2022)

Article Medicine, General & Internal

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

Bern-Thomas Nyang'wa, Catherine Berry, Emil Kazounis, Ilaria Motta, Nargiza Parpieva, Zinaida Tigay, Varvara Solodovnikova, Irina Liverko, Ronelle Moodliar, Matthew Dodd, Nosipho Ngubane, Mohammed Rassool, Timothy D. McHugh, Melvin Spigelman, David A. J. Moore, Koert Ritmeijer, Philipp du Cros, Katherine Fielding, TB-PRACTECAL Study Collaborators

Summary: The study aimed to evaluate the efficacy and safety of three all-oral regimens for the treatment of rifampin-resistant tuberculosis. The results showed that a 24-week all-oral regimen was noninferior to standard care and had fewer side effects.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Multidisciplinary Sciences

Emergence of phenotypic and genotypic antimicrobial resistance in Mycobacterium tuberculosis

Frank Kloprogge, Julio Ortiz Canseco, Lynette Phee, Zahra Sadouki, Karin Kipper, Adam A. Witney, Neil Stoker, Timothy D. McHugh

Summary: This study investigated the concentration dependency of isoniazid-rifampicin resistance emergence and found that rifampicin resistance is the result of non-specific mechanisms, while part of isoniazid resistance is associated with the accumulation of specific SNPs. Additionally, the study showed that resistance does not emerge in concentration-time profiles mimicking the granuloma.

SCIENTIFIC REPORTS (2022)

Article Genetics & Heredity

Mapping the phylogeny and lineage history of geographically distinct BCG vaccine strains

Linzy Elton, Sandeep Kasaragod, Helen Donoghue, Hussain A. Safar, Priscilla Amankwah, Alimuddin Zumla, Adam A. Witney, Timothy D. McHugh

Summary: The BCG vaccine has been used for tuberculosis prevention for over a century, but its efficacy varies across different regions. Genetic differences in BCG strains may contribute to this variation.

MICROBIAL GENOMICS (2023)

No Data Available